The Hematology Test Products market tracks instrument, reagent, and service revenue from ambulatory and laboratory-based testing. The majority of hematology testing occurs on stand-alone instrumentation, but future development efforts include laboratory automation tracks. This market segment includes Red Blood Cell (RBC), White Blood Cell (WBC), differential, and reticulocyte cell counts. It also includes CD4/CD8 counts conducted on hematology systems.
Hematology testing is conducted in both laboratory and ambulatory end-user settings. The ambulatory end-user segment typically includes low-volume 3-part or 5-part differential analyzers, while the laboratory end-user segment is composed of a broad range of systems across all throughput categories.
The leading worldwide manufacturers of hematology systems include:
Market Assessment/Monitoring Reports:
Relevant Conferences: